Table 1.
Type I | Type II | |
---|---|---|
Number (N) | 26 | 51 |
Median age in years (range)* | 62 (42-86) | 73 (46-85) |
Gender (M:F ratio) | 19:7 (2.7) | 31:20 (1.6) |
Prior CLL diagnosis# | 27% (7/26) | 73% (37/51) |
Sites (N)# | LN 25, BM 1 | LN 33, Spleen 4, BM 8, extranodal 6§ |
CD20+ | 52% (12/23) | 47% (23/49) |
PAX-5+ | 100% (20/20) | 100% (31/31) |
CD30+ | 100% (26/26) | 100% (51/51) |
CD15+ | 78% (18/23) | 92% (46/50) |
EBV+ | 65% (17/26) | 75% (38/51) |
ZAP-70+ | 57% (8/14) | 32% (6/19) |
Clonally related | 29% (4/14) | 53% (10/19) |
p=0.01 by student t-test
p<0.005 by Fisher exact test,
Includes liver (2), lung (2), pleura (1), and stomach (1).